Findings from this study are consistent with other studies showing that higher plasma NfL levels are associated with hippocampal atrophy and CMRgl reductions in brain regions preferentially affected by AD [6], and they extend these relationships to CU individuals at increased genetic risk for late-onset AD. The gene discussed is NEFL; the disease is hippocampal atrophy.